Noxzema

Description

NOXZEMA ULTIMATE CLEAR ANTI-BLEMISH PADS contain salicylic acid as the active ingredient. These pads are formulated to provide targeted treatment for blemishes, utilizing the properties of salicylic acid to help clear and prevent acne. The product is designed for topical application, offering a convenient dosage form for users seeking to manage their skin health effectively.

Uses and Indications

This drug is indicated for the treatment of acne. It effectively dries up acne pimples and helps prevent the formation of new acne pimples.

Dosage and Administration

Healthcare professionals should ensure that the skin is thoroughly cleaned prior to the application of the product. The affected area should be covered with a thin layer of the product, which should then be rinsed off thoroughly.

Initial application should begin with once daily, allowing for gradual increases to two or three times daily as needed or as directed by a physician. It is important to monitor for excessive drying of the skin; if bothersome dryness or peeling occurs, the frequency of application should be reduced to once daily or every other day.

Care should be taken to avoid contact with the eyes. In the event of contact, the area should be rinsed thoroughly with water.

Contraindications

Use of this product is contraindicated in children due to the risk of accidental ingestion. In the event of swallowing, immediate medical assistance should be sought or contact with a Poison Control Center is advised.

Warnings and Precautions

This product is intended for external use only. It is important to note that the formulation is flammable; therefore, it should be kept away from fire or flame to prevent any risk of ignition.

Healthcare professionals should advise patients that the concurrent use of this product with other topical acne medications may increase the likelihood of skin irritation and dryness. In the event that irritation occurs, it is recommended that patients limit their use to one topical acne medication at a time to mitigate adverse effects.

Additionally, this product should be stored out of reach of children. In cases of accidental ingestion, immediate medical assistance should be sought, or contact with a Poison Control Center is advised to ensure appropriate management.

Side Effects

Patients should be aware that this product is for external use only. It is classified as flammable, and therefore, it should be kept away from fire or flame to prevent any potential hazards.

During the use of this product, skin irritation and dryness are more likely to occur, particularly if another topical acne medication is used concurrently. In the event that irritation does occur, it is advised that patients limit their use to one topical acne medication at a time to mitigate these adverse reactions.

Drug Interactions

The concurrent use of this product with other topical acne medications may increase the risk of skin irritation and dryness. It is advisable to limit the use of topical acne treatments to one product at a time to minimize the potential for adverse effects. If skin irritation occurs, the use of additional topical acne medications should be discontinued until the irritation resolves.

Packaging & NDC

Below are the non-prescription pack sizes of Noxzema (salicylic acid). Columns show Packaging, Formulation Type, and Active Ingredient Strength.

Pediatric Use

Pediatric patients should be monitored closely to ensure the medication is kept out of reach of children. In the event of accidental ingestion, immediate medical assistance or contact with a Poison Control Center is advised.

For topical application, it is recommended to initiate treatment with one application daily to minimize the risk of excessive skin drying. Dosage may be gradually increased to two or three times daily as needed or directed by a healthcare professional. Should patients experience bothersome dryness or peeling, the frequency of application should be reduced to once daily or every other day.

Geriatric Use

There is no specific information regarding the use of this medication in geriatric patients, including dosage adjustments, safety concerns, or special precautions. Healthcare providers should exercise caution when prescribing this medication to elderly patients, as individual responses may vary. It is advisable to monitor these patients closely for any adverse effects or changes in efficacy, given the lack of targeted data for this population.

Pregnancy

There is no specific information regarding the use of this drug during pregnancy, including safety concerns, dosage modifications, or special precautions. Healthcare professionals should consider the lack of data when prescribing this medication to pregnant patients. It is advisable to weigh the potential benefits against any unknown risks to fetal outcomes. Women of childbearing potential should be counseled on the importance of effective contraception during treatment and the need to inform their healthcare provider if they become pregnant or plan to become pregnant while using this medication.

Lactation

There are no specific warnings or recommendations regarding the use of this product by lactating mothers. Additionally, there is no information available about the potential for excretion in breast milk or any associated risks to breastfed infants.

Renal Impairment

There is no information available regarding dosage adjustments, special monitoring, or safety considerations for patients with renal impairment. Healthcare professionals should exercise caution and consider the lack of specific guidance when prescribing to patients with reduced kidney function.

Hepatic Impairment

There is no information available regarding the use of this medication in patients with hepatic impairment. Consequently, there are no dosage adjustments, special monitoring requirements, or precautions specified for individuals with compromised liver function. Healthcare professionals should exercise clinical judgment when considering the use of this medication in patients with liver problems, as the absence of specific guidance necessitates careful evaluation of the patient's overall health status and liver function.

Overdosage

In the event of an overdosage, immediate medical intervention is crucial. If the substance is ingested, it is imperative to seek medical assistance or contact a Poison Control Center without delay.

Healthcare professionals should be aware that prompt action can significantly influence the outcome of an overdosage situation. Symptoms of overdosage may vary depending on the specific substance involved; therefore, a thorough assessment and monitoring of the patient are essential.

Management procedures should include supportive care and symptomatic treatment as necessary. Continuous evaluation of the patient's condition is recommended to address any complications that may arise.

Nonclinical Toxicology

No teratogenic or non-teratogenic effects have been reported in the available nonclinical studies. Additionally, there is no information regarding animal pharmacology and toxicology. The absence of data limits the assessment of potential risks associated with the use of the compound in these contexts.

Postmarketing Experience

No postmarketing experience details are available in the insert.

Patient Counseling

Healthcare providers should advise patients to keep the medication out of reach of children to prevent accidental ingestion. It is important to emphasize that if the medication is swallowed, patients should seek medical help or contact a Poison Control Center immediately. This guidance is crucial for ensuring patient safety and minimizing potential risks associated with accidental exposure.

Storage and Handling

The product is supplied in configurations that include specific NDC numbers. It should be stored at room temperature, ensuring that it is kept away from fire or flame to maintain safety and integrity. Once opened, the product must be discarded to prevent any potential contamination or degradation.

Additional Clinical Information

The product is administered topically and is intended for external use only. Clinicians should advise patients that the formulation is flammable and should be kept away from fire or flame. When using this product, patients are cautioned that skin irritation and dryness may increase if another topical acne medication is used concurrently. It is recommended that only one topical acne medication be used at a time to minimize the risk of irritation.

Patients should be instructed to keep the product out of reach of children and to seek medical assistance or contact a Poison Control Center immediately if swallowed. Additionally, care should be taken to avoid contact with the eyes; in the event of contact, the eyes should be rinsed thoroughly with water.

Drug Information (PDF)

This file contains official product information for Noxzema, including active ingredients, dosage, warnings, and labeling as submitted by the manufacturer for OTC distribution.

View product document (PDF)